Tech Company Financing Transactions
Theradaptive Funding Round
Maryland Stem Cell Research Fund invested in a capital raise for Theradaptive. This venture round was announced on 5/22/2024.
Transaction Overview
Company Name
Announced On
5/22/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support human clinical trials for its lead product, OsteoAdapt SP.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5350 Partners Court B
Frederick, MD 21703
USA
Frederick, MD 21703
USA
Phone
Website
Email Address
Overview
Theradaptive is developing a therapeutic delivery platform for multiple clinical indications including immuno-oncology, orthopedics and soft tissue repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Luis Alvarez
Vice President
David Stewart
Browse more venture capital transactions:
Prev: 5/22/2024: Captain T Cell venture capital transaction
Next: 5/22/2024: Patronus AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs